Board of Directors                                                                                                                 

Jonathan D Freeman BA Hons MBA, Chairman & Non-executive Director

Jonathan is an experienced corporate financier and company director. He has extensive experience of quoted companies, financial services and of FCA regulated entities. This experience is important to the Group as it is quoted on AIM. Jonathan also chairs the Audit Committee and the Remuneration Committee.

Jonathan is also the senior independent Non-executive Director of Futura Medical Plc and chairs their Audit Committee and Remuneration Committee. He is also a non-executive director of Braveheart Investment Group plc and, since the period end, became a non-executive director of European Wealth Limited. Jonathan joined became a Non-executive Director on 28 March 2012 and became Chairman on 8 December 2015.

Martin Lampshire, Non-executive Director

Martin started his career in Lloyds Bank's Commercial Services division in 1989 after completing the ACIB qualification.

He has over twenty years experience in Corporate Broking, working for a number of city based firms including Teather & Greenwood, Charles Stanley, Hichens Harrison Stockbrokers and Daniel Stewart Stockbrokers. 

He has assisted many companies in a variety of equity raises including IPO's, secondary fundraisings, vendor and private placings across a variety of sectors. He has also worked in a number of overseas financial centres including Hong Kong, Singapore, Kuala Lumpur and Dubai. Martin joined the board as a Non-executive director on 14 January 2019.

John Treacy non-executive director 

Mr Treacy is a London-based experienced small cap financier who specialises in working with growing companies. He qualified as a solicitor in the London office of a major international law firm where he specialised in Capital Markets and Mergers & Acquisitions. From there he moved to practice corporate finance in the advisory teams of several prominent UK brokerages where he acted as an adviser to a number of AIM companies and advised on numerous IPOs, acquisitions, debt restructurings and placings